#insilico Tech News.
1 story in the last 7 days
The latest insilico news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks insilico across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
AIFinancial Timesabout 3 hours ago
Insilico Starts Phase III Trial for RentosertibInsilico Medicine initiated a Phase III clinical trial for Rentosertib, an AI-empowered TNIK inhibitor targeting idiopathic pulmonary fibrosis. The trial evaluates the drug's efficacy and safety in patients. Rentosertib was discovered using Insilico's artificial intelligence platform for drug development.
Summaries by ByteBrief